PAGUE MENOS (PGMN3) Main Indicators
Basic Data - PGMN3
Company | PAGUE MENOS |
Corporate Name | EMPREENDIMENTOS PAGUE MENOS S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | Comércio de produtos farmacêuticos. perfumarias e afins. sem manipulação de fórmulas. |
Share | PGMN3 |
Quote Date | 04/01/2025 |
Share Type | ON |
Last Closing | R$ 3.40 |
Quotation Factor | 1 Share |
Financial Volume | R$ 7.69 M |
Last Statement | DFP - 12/31/2024 |
Sector | Saúde |
Subsector | Comércio e Distribuição |
Segment | Medicamentos e Outros Produtos |
Participation Indexes | IBRA, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
Updated 04/02/2025 |
Relative Prices - PGMN3
Price/Earnings | 20.53 |
Price/SBV | 0.78 |
Price/Net Sales | 0.17 |
Price/CFO | 5.51 |
Price/FCF | 7.06 |
Price/Total Assets | 0.24 |
Price/EBIT | 3.69 |
Price/Working Capital | 1.72 |
Price/NCAV | -0.42 |
EV/EBIT | 5.89 |
EV/EBITDA | 3.10 |
EV/Net Sales | 0.27 |
EV/CFO | 8.80 |
EV/FCF | 11.29 |
EV/Total Assets | 0.38 |
Company Market Cap | R$ 2.12 B |
Enterprise Value | R$ 3.38 B |
Current Financial Statement Date | 12/31/2024 |
Current Share Price | R$ 3.40 |
Share Price Date | 04/01/2025 |
Dividend Yield | 7.44% |
Updated 04/02/2025 |
Income Statement - PGMN3
Net Revenue | R$ 12.64 B |
Gross Result | R$ 4.03 B |
EBIT | R$ 574.27 M |
Depreciation and Amortization | - R$ 518.13 M |
EBITDA | R$ 1.09 B |
Net Profit | R$ 103.10 M |
Net Profit/Share | R$ 0.18 |
Updated 03/13/2025 |
Net Revenue | R$ 3.35 B |
Gross Result | R$ 1.07 B |
EBIT | R$ 148.86 M |
Depreciation and Amortization | - R$ 131.75 M |
EBITDA | R$ 280.61 M |
Net Profit | R$ 66.46 M |
Profit/Share | R$ 0.12 |
Updated 03/13/2025 |
Price and Volume Behavior - PGMN3
Lowest Price 52 weeks | R$ 2.03 |
Highest Price 52 weeks | R$ 3.40 |
Variation 2025 | 17.70% |
Variation 1 year | 37.98% |
Variation 2 years(total) | 29.92% |
Variation 2 years(yearly) | 13.94% |
Variation 3 years(total) | -57.28% |
Variation 3 years(yearly) | -24.67% |
Variation 4 years(total) | -54.40% |
Variation 4 years(yearly) | -17.81% |
Variation 5 years(total) | - |
Variation 5 years(yearly) | - |
Average Daily Volume (3 months) | R$ 4.56 M |
Updated 04/02/2025 |
Returns and Margins - PGMN3
Return on Initial Tangible Capital | 10.44% |
Return on Initial Invested Capital | 9.84% |
Pre-Tax Return on Initial Tangible Capital | 15.81% |
Pre-Tax Return on Initial Invested Capital | 14.92% |
Return on Initial Shareholder´s Equity | 3.89% |
Return on Initial Asset | 1.15% |
Gross Margin | 31.85% |
Net Margin | 0.82% |
EBIT Margin | 4.54% |
EBITDA Margin | 8.64% |
Initial Asset Turnover | 1.41 |
Financial Leverage | 3.31 |
Liabilities/Net Worth | 2.31 |
Net Debt/EBITDA | 1.16 |
Updated 03/13/2025 |
Balance Sheet - PGMN3
Cash and Cash Equivalents | R$ 149.13 M |
Total Assets | R$ 8.98 B |
Short-Term Debt | R$ 369.75 M |
Long-Term Debt | R$ 1.05 B |
Gross Debt | R$ 1.42 B |
Net Debt | R$ 1.27 B |
Shareholder´s Equity | R$ 2.71 B |
Share Book Value | R$ 4.77 |
Common Shares | 569,249,470 |
Preferred Shares | 0 |
Total | 569,249,470 |
Common Shares in Treasury | 7,353,440 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 7,353,440 |
Common Shares (Except Treasury) | 561,896,030 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 561,896,030 |
Updated 03/13/2025 |
Cash Flow - PGMN3
Operating Cash Flow | R$ 384.48 M |
Cash Flow from Investments | - R$ 91.73 M |
Financing Cash Flow | - R$ 582.13 M |
Increase (Reduction) in Cash and Equivalents | - R$ 289.37 M |
Updated 03/13/2025 |
Operating Cash Flow | R$ 182.27 M |
Cash Flow from Investments | - R$ 39.22 M |
Financing Cash Flow | - R$ 163.52 M |
Increase (Reduction) in Cash and Equivalents | - R$ 20.47 M |
Updated 03/13/2025 |
Experimental - PGMN3
CAPEX 3 months | - R$ 29.47 M |
Free Cash Flow 3 months | R$ 152.79 M |
CAPEX 12 months | - R$ 84.65 M |
Free Cash Flow 12 months | R$ 299.83 M |
Updated 03/13/2025 |